GTCM
JAZZ icon

Gyon Technologies Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Gyon Technologies Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,866
Closed -$635K – 428
2021
Q1 		$635K Sell
3,866
-3,360
-46% -$553K 0.28% 108
2020
Q4 		$1.19M Buy
7,226
+5,353
+286% +$797K 0.41% 75
2020
Q3 		$267K Buy
+1,873
New +$232K 0.21% 177

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gyon Technologies Capital Management's JAZZ Position: Q2 2021 in Review

Gyon Technologies Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2021, closing a stake of 3,866 shares — an estimated $635K sold.

Gyon Technologies Capital Management first reported a position in JAZZ in Q3 2020 and held it in 3 quarters. The position peaked at $1.19M in Q4 2020. 505 funds tracked by Wall St. Rank hold JAZZ as of Q2 2021.

  • Gyon Technologies Capital Management reported no remaining Jazz Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 3,866 Jazz Pharmaceuticals shares in Q2 2021, an estimated $635K.
  • Gyon Technologies Capital Management first reported a position in Jazz Pharmaceuticals in Q3 2020 and held it in 3 quarters.
  • Gyon Technologies Capital Management's Jazz Pharmaceuticals position peaked at $1.19M in Q4 2020.
  • 505 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2021.

Based on Gyon Technologies Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.